Alosetron hydrochloride
- Level
- Commodity
- Parent
- 51171700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171720This classification denotes a 5-ht3 receptor antagonist with the molecular formula C17H18N4O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2F5R1A46YW, chemically known as 2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1h-pyrido(4,3-b)indol-1-one monohydrochloride but more generally known as alosetron hydrochloride, which bears US NIH Compound Identifier 60758. The base compound, Alosetron, comes in base and hydrochloride forms. European Medicines Agency schedules Alosetron hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12461MIG. Most nations, for tariff and trade purposes, schedule alosetron hydrochloride under HS 29337900 and SITC 51561. As of Q4 2014, ALOSETRON HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Alosetron hydrochloride bears US NLM identifiers UMLS ID C0291771 and NCI Concept Code C47386. SMILES: CC1C(NC[NH]1)CN2CCC3C(C4CCCCC4N3C)C2=O.CL.
Same parent
Under 51171700 · 24Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.